• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Juvenile Diabetes Research Foundation (JDRF)

FDA approves ready-to-use liquid glucagon from Xeris

September 12, 2019 By Sean Whooley

Xeris Pharmaceuticals logo - updated

Xeris Pharmaceuticals (NSDQ:XERS) said yesterday that the FDA has approved its Gvoke glucagon injection for the treatment of hypoglycemia. Gvoke is a ready-to-use, room-temperature, stable liquid glucagon designed to treat severe hypoglycemia in pediatric and adult patients with Type 1 diabetes aged two years old or above. Chicago-based Xeris’ Gvoke may be administered with a pre-filled […]

Filed Under: Auto-injectors, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Wall Street Beat Tagged With: FDA, Juvenile Diabetes Research Foundation (JDRF), xerispharmaceuticals

Researchers tout use of closed-loop insulin delivery system

October 3, 2018 By Sarah Faulkner

JDRF - updated logo

At this year’s meeting of the European Association for the Study of Diabetes, researchers reported that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in people with poorly controlled Type 1 diabetes. The JDRF-funded study included 44 men and 42 women with Type 1 […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Juvenile Diabetes Research Foundation (JDRF)

SFC Fluidics lands JDRF support for interoperable insulin patch pump

July 30, 2018 By Sarah Faulkner

SFC Fluidics

SFC Fluidics said today that it inked a deal with JDRF to support the development of an insulin patch pump with open-protocol communication features. SFC Fluidics plans to use the two-year funding deal from JDRF to speed up the development of a patch pump that securely connects with other devices, like a continuous glucose monitor […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: Juvenile Diabetes Research Foundation (JDRF), sfcfluidics

JDRF tackles insulin consistency, potency at U.S. pharmacies

April 11, 2018 By Sarah Faulkner

diabetes

JDRF is teaming up with the American Diabetes Association and the Leona M. and Harry B. Helmsley Charitable Trust to support research evaluating the consistency and potency of insulin purchased at retail pharmacies in the U.S. The group called for proposals from analytical laboratories to assess the activity of insulin in vials and cartridges, looking […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: americandiabetesassociation, Juvenile Diabetes Research Foundation (JDRF)

Congress doles out $300m to fund diabetes research

February 9, 2018 By Sarah Faulkner

capitol hill

Congress today approved a two-year extension of the Special Diabetes Program, giving the National Institutes of Health $300 million to fund research into new therapies and technologies for people with Type I diabetes. The program, which has historically garnered bipartisan support, was last reauthorized in 2015 when lawmakers budgeted $150 million over two years for […]

Filed Under: Diabetes, Featured, Pharmaceuticals, Research & Development Tagged With: Juvenile Diabetes Research Foundation (JDRF), National Institutes of Health

Cam Med partners with JDRF to develop flexible, bandage-like insulin patch pump

February 5, 2018 By Sarah Faulkner

JDRF

Medical device startup Cam Med has partnered with JDRF to develop an ultra-thin, flexible insulin patch pump to be used with next-generation artificial pancreas systems. The goal of the partnership is to speed up the development of Cam Med’s Evopump – a conformable, disposable patch pump – so that the device can be integrated into […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: cammed, Juvenile Diabetes Research Foundation (JDRF)

Report: Advocacy groups urge Congress to fund diabetes research programs

January 29, 2018 By Sarah Faulkner

diabetes

Advocacy groups have reportedly warned Congress that if lawmakers don’t find permanent funding solutions for diabetes research programs, it could jeopardize important work being done around the country to help people living with diabetes. Politicians on Capitol Hill have provided funding that will support the Special Diabetes Program and the Special Diabetes Program for Indians through […]

Filed Under: Diabetes, Featured, Pharmaceuticals, Policy, Wall Street Beat Tagged With: Juvenile Diabetes Research Foundation (JDRF), National Institutes of Health

SFC Fluidics inks deal with JDRF to develop automated insulin delivery system

January 22, 2018 By Sarah Faulkner

SFC Fluidics

SFC Fluidics has inked a two-year deal with JDRF to develop an automated insulin delivery system that combines a continuous glucose monitor and an insulin delivery algorithm into a single disposable device. JDRF is slated to provide funding to the medical device company as part of its Artificial Pancreas Project, which aims to accelerate the […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: Bigfoot Biomedical, Juvenile Diabetes Research Foundation (JDRF), Medtronic, sfcfluidics

Semma Therapeutics closes $114m round to advance cell therapy for Type I diabetes

November 30, 2017 By Sarah Faulkner

Semma Therapeutics

Semma Therapeutics has closed an oversubscribed $114 million Series B round to help fund the development of its encapsulated stem cell-derived islet therapy for Type I diabetes. The Cambridge, Mass.-based company reported that it plans to use the newly-acquired funds to bring its cell therapy through clinical proof-of-concept studies, as well as explore other regenerative […]

Filed Under: Diabetes, Featured, Funding Roundup, Stem Cells Tagged With: Juvenile Diabetes Research Foundation (JDRF), Medtronic, Novartis, Semma Therapeutics

JDRF touts win after Anthem decides to cover artificial pancreas systems

November 17, 2017 By Sarah Faulkner

JDRF

JDRF said today it successfully persuaded Anthem to cover artificial pancreas systems, after meeting the health insurer as part of its Coverage2Control campaign. America’s 25 largest health insurers now cover Medtronic‘s (NYSE:MDT) MiniMed system, according to the organization. “This is a great victory for the T1D community. By taking this tremendous step, Anthem is giving […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Anthem, Juvenile Diabetes Research Foundation (JDRF), Medtronic

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS